Stéphane Bancel, Moderna CEO (Andrew Harnik/AP Images)

Truce: Mod­er­na backs down in patent fight with NIH as it touts ear­ly boost­er da­ta against Omi­cron

Mod­er­na has backed down on its patent fight with the NIH, call­ing a truce by drop­ping its patent ap­pli­ca­tion for now.

Fol­low­ing a heat­ed feud re­gard­ing who in­vent­ed its life­sav­ing Covid-19 vac­cine that was in­creas­ing­ly spilling in­to pub­lic view, the biotech said it “has de­cid­ed at this time not to pur­sue” a patent is­suance for the mR­NA se­quence of its jab. But Mod­er­na al­so filed a con­tin­u­a­tion ap­pli­ca­tion so that some of the claims may still be is­sued lat­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.